Peroxisome proliferator-activated receptor-γ as a regulator of lung inflammation and repair

Proceedings of the American Thoracic Society

Volumn 2, Issue 3, 2005, Pages 226-231

  Standiford, Theodore J ^a,b   Keshamouni, Venkateshwar C ^a   Reddy, Raju C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b 6301 MSRB III ^*  (United States)

Author keywords

ARDS; Gene regulation; Transcriptional factors

Indexed keywords

CELL NUCLEUS RECEPTOR; HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC DISEASE; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; CELLULAR IMMUNODEFICIENCY; CONFERENCE PAPER; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; INSULIN SENSITIVITY; LEUKOCYTE; LEUKOCYTE MIGRATION; LIPID METABOLISM; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG CANCER; LUNG DISEASE; LUNG INJURY; LUNG PARENCHYMA; NEUTROPHIL; NONHUMAN; PROTEIN FAMILY; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REPERFUSION INJURY; RESPIRATORY TRACT DISEASE; STROMA CELL; TISSUE REPAIR;

ANIMALS; HUMANS; INFLAMMATION; LUNG NEOPLASMS; NEUTROPHILS; PPAR GAMMA; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY ALVEOLI; REPERFUSION INJURY; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY HYPERSENSITIVITY;

EID: 27144456205     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200501-010AC     Document Type: Conference Paper

References (62)

1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-1349.
2. Pugin J, Verghese G, Widmer MC, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999;27: 304-312.
3. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-611.
4. Hess R, Staubli W, Riess W. Nature of hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 1965;208:856-888.
5. Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors. Lancet 1999;354:141-148.
6. Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 2000;40:491-518.
7. Dowell P. Identification of nuclear receptor co repressor as a peroxisome proliferators-activated receptor-α interacting protein. J Biol Chem 1999; 274:15901-15907.
8. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994;79:1147-1156.
9. Dayes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Revs/Immunol 2002;2:748-759.
10. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998;391:82-86.
11. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;91:79-82.
12. Bishop-Bailey D. Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 2000;129:S23-S34.
13. Yu K, Bayona W, Kallen CB, Harding HB, Ravera CP, McMahon G, Brown M, Lazar M. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 1995;270:23975-23983.
14. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM, Spiegelman BM. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev 1996;10:974-984.
15. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM. A prostaglandin metabolite binds peroxisome proliferator-activated receptor y promotes adipocyte differentiation. Cell 1995;83:813-819.
16. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors áand y. Proc Natl Acad Sci USA 1997;94:4318-4323.
17. Nagy L, Tontonoz P, Alvarez JGA, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression gene expression through ligand activation of PPAR-γ. Cell 1998;93:229-240.
18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-12956.
19. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1997;272:3406-3410.
20. Chung SL, Kand BK, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor κB. J Biol Chem 2000;275:32681-32687.
21. Marx N, Sukhova G, Murphy C, Libby P, Plutzky J. Macrophages in human atheroma contain PPARgamma: differentiation- dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPAR gamma activation in mononuclear phagocytes in vitro. Am J Pathol 1998; 153:17-23.
22. Delerive P, DeBosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B. Peroxisome proliferator-activated receptor-α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem 1999;274:32048-32054.
23. Delerive P, Martin-Nizard F, Chinetti G, Trottein F, Fruchart JC, Najib J, Duriez P, Staels B. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator proten-1 signaling pathway. Circ Res 1999;85:394-402.
24. Delerive P, Gervois P, Fruchart JC, Staels B. Induction of 1κBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 2000;275:36703-36707.
25. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AGP, Pettersson S, Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-7 and ReIA. Nat Immunol 2004;5:104-112.
26. Keshamouni VG, Reddy RC, Arenberg DA, Joel B, Thannickal VJ, Kalemkerian GP, Standiford TJ. Peroxisome proliferator-activated receptor-7 activation inhibits tumor progression in non-small-cell lung cancer. Oncogene 2004;23:100-108.
27. Keshamouni VG, Arenberg DA, Reddy RC, Newstead MJ, Anthwal S, Standiford TJ. PPAR-7 activation inhibits angiogenesis by blocking ELR+ CXC chemokine production in non small cell lung cancer. Neoplasia 2005;7:294-301.
28. Chinetti G, Griglio S, Antonucci M, Torra IP. Delerive P, Majd Z, Chapman J, Najib J, Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998;273:25573-25580.
29. Harris SG, Phipps RP. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation in naive mouse T cells induces cell death. Ann N Y Acad Sci 2000;905:297-300.
30. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, Satoh S, Nakano R, Ishii C, Sugiyama S, et al. PPAR7 mediates high-fat-diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999;4:597-609.
31. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM, PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001;7:48-52.
32. Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen XQ, Vanbogelen R, Leff T. Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone. Diabetes 2000; 49:539-547.
33. Nakajima A, Wada K, Miki H, Kubota N, Nakajima N, Terauchi Y, Ohnishi S. Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury. Gastroenterology 2001;120:460-469.
34. Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999;104:383-389.
35. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000;106:189-197.
36. Cuzzocrea S, Pisano B, Dugo L, Ianaro A, NSA, Patel, DiPaola R, Genovese T, Chatterje PK, Fulia F, Cuzzocrea E, Di Rosa M, Caputi AP, Thiemermann C. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces the development of nonseptic shock induced by zymosan in mice. Crit Care Med 2004;32:457-466.
37. Reynolds K, Novosad B, Hoffhines A, Gipson J, Johnson J, Peters J, Gonzales F, Gimble J, Hill M. Pretreatment with troglitazone decreases lethality during endotoxemia in mice. J Endotoxin Res 2002;8:307-314.
38. Reddy RC, Keshamouni VG, Jaigirdar SH, Zeng X, Leff T, Thannickal VJ, Standiford TJ. Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands. Am J Physiol Lung Cell Mol Physiol 2004;286:L613-L619.
39. Asada K, Sasaki S, Suda T, Chica K, Nakamura H. Antiinflammatory roles of peroxisome proliterator-activated receptor γ in human alveolar macrophages. Am J Respir Crit Care Med 2004;169:195-200.
40. Christensen PJ, Goodman RE, Pastoriza L, Moore B, Toews GB. Animal model: induction of lung fibrosis in the mouse by intratracheal instillation of fluorescein isothiocyanate is not T-cell dependent. Am J Pathol 1999;155:1773-1779.
41. 2 on acute lung injury induced by lipopolysaccharide in mice. Eur J Pharmacol 2003;481:261-269.
42. Kintscher U, Goetze S, Wakino S, Kim S, Nagpal S, Chandraratna RA, Graf K, Fleck E, Hsueh WA, Law RE. Peroxisome proliferators-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur J Pharmacol 2000;401:259.
43. Ueki S, Matsuwaki Y, Kayaba H, Oyamada H, Kanda A, Usami A, Saito N, Chihara J. Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation. Int Arch Allergy Immunol 2004;134:30-36.
44. Rennard SI, Bitterman PB, Crystal RG. Response of the lower respiratory tract to injury. Mechanisms of repair of the parenchymal cells of the alveolar wall. Chest 1983;84:735-739.
45. Wang AC, Dai X, Luu B, Conrad DJ. Peroxisome proliferators-activated receptor-gamma regulates airway epithelial cell activation. Am J Respir Cell Mol Biol 2001;24:688-693.
46. Marinelli WA, Henke CA, Harmon KR, Hertz MI, Bitterman PB. Mechanisms of alveolar fibrosis after acute lung injury. Clin Chest Med 1990;11:657-659.
47. Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. Am J Pathol 1994;145:114-120.
48. Masamune A, Kikuta K, Satoh M, Sakai Y, Satoh A, Shimosegawa T. Ligands of perioxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells. J Biol Chem 2002;277:141-147.
49. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and pro-inflammatory actions in hepatic stellate cells. Gastroenterology 2000;119:466-478.
50. Kon K, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Kitamura T, Takei Y, Sato N. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun 2002;291:55-61.
51. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Redonnet M, Phipps RP, Sime PJ. PPAR gamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production; implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2005;288:1146-1153.
52. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-deoxy prostaglandin J2. J Biol Chem 2002;277:10459-10466.
53. Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, Yoshikawa T, Kitamura N. Protective effects of pre-ischemic treatment with pioglizatone, a peroxisome proliferator-activated receptor-γ ligand, on lung ischemia-reperfusion injury in rats. Eur J Cardiothorac Surg 2004; 25:530-536.
54. Okada M, Yan SF, Pinsky DJ. Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J 2002;16:1861-1868.
55. Woerly G, Honda K, Loyens M, Papin J-P, Auwerx J, Staels B, Capron M, Dombrowicz D. Peroxisome proliferator-activated receptors α and γ down-regulate allergic inflammation and eosinophil activation. J Exp Med 2003;198:411-421.
56. Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, Whittacker P. PPAR-α and γ but not -δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-κB-independent effect. Br J Pharmacol 2003;139:163-171.
57. Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret M-C, Mechighel P, Megret J, Leseche G, Aubier M, Pretolani M. Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways. Am J Respir Crit Care Med 2001;164:1487-1494.
58. Said JW, Heber D, Koeffter HP. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 1998;95:8806-8811.
59. Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 1998; 58:3344-3352.
60. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, Zhang M, Fletcher C, Singer S, Spiegelman BM. Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1998;1:465-470.
61. Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman BM, Eng C. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 1999;3:799-804.
62. Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ. Peroxisome proliferator-activated receptor-γ is deficient in alveolar macrophages from patients with alveolar proteinosis. Am J Respir Cell Mol Biol 2003;29:677-682.